158 related articles for article (PubMed ID: 37250845)
1. Phylogenetic analysis of promoter regions of human
Farooqi N; Rahman A; Ali Y; Ali K; Khan MEH; Jones DA; Abdelkarim M; Ullah F; Jalil F
Open Life Sci; 2023; 18(1):20220591. PubMed ID: 37250845
[TBL] [Abstract][Full Text] [Related]
2. Severe, fatal multisystem manifestations in a patient with dolichol kinase-congenital disorder of glycosylation.
Lieu MT; Ng BG; Rush JS; Wood T; Basehore MJ; Hegde M; Chang RC; Abdenur JE; Freeze HH; Wang RY
Mol Genet Metab; 2013 Dec; 110(4):484-9. PubMed ID: 24144945
[TBL] [Abstract][Full Text] [Related]
3. Congenital disorders of glycosylation: an update on defects affecting the biosynthesis of dolichol-linked oligosaccharides.
Haeuptle MA; Hennet T
Hum Mutat; 2009 Dec; 30(12):1628-41. PubMed ID: 19862844
[TBL] [Abstract][Full Text] [Related]
4. Dolichol kinase deficiency (DOLK-CDG): Two new cases and expansion of phenotype.
Rush ET; Baker CV; Rizzo WB
Am J Med Genet A; 2017 Sep; 173(9):2428-2434. PubMed ID: 28816422
[TBL] [Abstract][Full Text] [Related]
5. A Novel Compound Heterozygous Gene Mutation of Dolichol Kinase Deficiency (DOLK-CDG).
Yu S; Zhang Y; Chen Z; Song J; Wang C
Endocr Metab Immune Disord Drug Targets; 2023; 23(2):235-241. PubMed ID: 35674301
[TBL] [Abstract][Full Text] [Related]
6. Autosomal recessive dilated cardiomyopathy due to DOLK mutations results from abnormal dystroglycan O-mannosylation.
Lefeber DJ; de Brouwer AP; Morava E; Riemersma M; Schuurs-Hoeijmakers JH; Absmanner B; Verrijp K; van den Akker WM; Huijben K; Steenbergen G; van Reeuwijk J; Jozwiak A; Zucker N; Lorber A; Lammens M; Knopf C; van Bokhoven H; Grünewald S; Lehle L; Kapusta L; Mandel H; Wevers RA
PLoS Genet; 2011 Dec; 7(12):e1002427. PubMed ID: 22242004
[TBL] [Abstract][Full Text] [Related]
7. Hypoglycosylation due to dolichol metabolism defects.
Denecke J; Kranz C
Biochim Biophys Acta; 2009 Sep; 1792(9):888-95. PubMed ID: 19419701
[TBL] [Abstract][Full Text] [Related]
8. Dolichol kinase deficiency (DOLK-CDG) with a purely neurological presentation caused by a novel mutation.
Helander A; Stödberg T; Jaeken J; Matthijs G; Eriksson M; Eggertsen G
Mol Genet Metab; 2013 Nov; 110(3):342-4. PubMed ID: 23890587
[TBL] [Abstract][Full Text] [Related]
9. Ethanol-induced impairment in the biosynthesis of N-linked glycosylation.
Welti M; Hülsmeier AJ
J Cell Biochem; 2014 Apr; 115(4):754-62. PubMed ID: 24243557
[TBL] [Abstract][Full Text] [Related]
10. Fatal Neonatal DOLK-CDG as a Rare Form of Syndromic Ichthyosis.
Komlosi K; Claris O; Collardeau-Frachon S; Kopp J; Hausser I; Mazereeuw-Hautier J; Jonca N; Zimmer AD; Sanlaville D; Fischer J
Front Genet; 2021; 12():719624. PubMed ID: 34956305
[TBL] [Abstract][Full Text] [Related]
11. The yeast ALG11 gene specifies addition of the terminal alpha 1,2-Man to the Man5GlcNAc2-PP-dolichol N-glycosylation intermediate formed on the cytosolic side of the endoplasmic reticulum.
Cipollo JF; Trimble RB; Chi JH; Yan Q; Dean N
J Biol Chem; 2001 Jun; 276(24):21828-40. PubMed ID: 11278778
[TBL] [Abstract][Full Text] [Related]
12. A novel carbohydrate-deficient glycoprotein syndrome characterized by a deficiency in glucosylation of the dolichol-linked oligosaccharide.
Burda P; Borsig L; de Rijk-van Andel J; Wevers R; Jaeken J; Carchon H; Berger EG; Aebi M
J Clin Invest; 1998 Aug; 102(4):647-52. PubMed ID: 9710431
[TBL] [Abstract][Full Text] [Related]
13. Abnormal synthesis of dolichol-linked oligosaccharides in carbohydrate-deficient glycoprotein syndrome.
Krasnewich DM; Holt GD; Brantly M; Skovby F; Redwine J; Gahl WA
Glycobiology; 1995 Jul; 5(5):503-10. PubMed ID: 8563136
[TBL] [Abstract][Full Text] [Related]
14. A case of fatal Type I congenital disorders of glycosylation (CDG I) associated with low dehydrodolichol diphosphate synthase (DHDDS) activity.
Sabry S; Vuillaumier-Barrot S; Mintet E; Fasseu M; Valayannopoulos V; Héron D; Dorison N; Mignot C; Seta N; Chantret I; Dupré T; Moore SE
Orphanet J Rare Dis; 2016 Jun; 11(1):84. PubMed ID: 27343064
[TBL] [Abstract][Full Text] [Related]
15. A forward genetic screen identifies Dolk as a regulator of startle magnitude through the potassium channel subunit Kv1.1.
Meserve JH; Nelson JC; Marsden KC; Hsu J; Echeverry FA; Jain RA; Wolman MA; Pereda AE; Granato M
PLoS Genet; 2021 Jun; 17(6):e1008943. PubMed ID: 34061829
[TBL] [Abstract][Full Text] [Related]
16. A 13-amino acid peptide in three yeast glycosyltransferases may be involved in dolichol recognition.
Albright CF; Orlean P; Robbins PW
Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7366-9. PubMed ID: 2678101
[TBL] [Abstract][Full Text] [Related]
17. From glycosylation disorders to dolichol biosynthesis defects: a new class of metabolic diseases.
Cantagrel V; Lefeber DJ
J Inherit Metab Dis; 2011 Aug; 34(4):859-67. PubMed ID: 21384228
[TBL] [Abstract][Full Text] [Related]
18. Enzymes that recognize dolichols participate in three glycosylation pathways and are required for protein secretion.
Orlean P
Biochem Cell Biol; 1992 Jun; 70(6):438-47. PubMed ID: 1333231
[TBL] [Abstract][Full Text] [Related]
19. Dolichol phosphate mannose synthase: a Glycosyltransferase with Unity in molecular diversities.
Banerjee DK; Zhang Z; Baksi K; Serrano-Negrón JE
Glycoconj J; 2017 Aug; 34(4):467-479. PubMed ID: 28616799
[TBL] [Abstract][Full Text] [Related]
20. A new type of congenital disorders of glycosylation (CDG-Ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis.
Thiel C; Schwarz M; Peng J; Grzmil M; Hasilik M; Braulke T; Kohlschütter A; von Figura K; Lehle L; Körner C
J Biol Chem; 2003 Jun; 278(25):22498-505. PubMed ID: 12684507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
